UIC Multi-Ethnic DCM Registry for Heart Failure and Dilated Cardiomyopathy

This study is creating a registry to better understand Dilated Cardiomyopathy (DCM), a condition where the heart struggles to pump blood. DCM affects minority groups more often and severely, but most research has focused on White individuals. Researchers want to see if the genetic causes of DCM are the same in African American and Hispanic/Latino patients. They also want to understand how medical, social, and financial stress impacts the disease in these groups. The study aims to identify specific genetic changes (Likely Pathogenic/Pathogenic Variants) at the start of the study. You can join if you are 18 or older, seen at a UIH site, and can provide consent. The study is currently unclear on its recruitment status and plans to include 1500 participants.

Study design
This is an observational study, meaning researchers will collect information without providing any specific intervention. It aims to enroll 1500 participants.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Not specified.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07145138

UIC Multi-Ethnic DCM Registry

Recruiting
Not specifiedAges 18+Observational
University of Illinois at Chicago
~1,500 participants
Updated 2025-08-28 on ClinicalTrials.gov

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Likely Pathogenic/Pathogenic Variants
Measured over Baseline
Heart Failure
Dilated Cardiomyopathy (DCM)
1 sites across 1 states
Illinois1

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Must be at least 18 years of age and be admitted to or seen at a UIH site.
Subjects must be willing and able to give written, informed consent

Exclusion

Adults who are unable to provide consent
Women who are pregnant at the baseline visit,
Prisoners
Individuals who are not yet adults (infants, children, teenagers).
  • Likely Pathogenic/Pathogenic VariantsBaseline

    Utilizing genomic sequencing, the investigators will obtain blood samples at baseline for study participants and identify utilizing genomic sequencing the prevalence of likely pathogenic/pathogenic (LP/P) variants in dilated cardiomyopathy patients across race-ethnicity.